Kavita Babu to Narcotic Antagonists
This is a "connection" page, showing publications Kavita Babu has written about Narcotic Antagonists.
Connection Strength
1.595
-
Babu KM, Brent J, Juurlink DN. Prevention of Opioid Overdose. N Engl J Med. 2019 06 06; 380(23):2246-2255.
Score: 0.561
-
Bradley ES, Liss D, Carreiro SP, Brush DE, Babu K. Potential uses of naltrexone in emergency department patients with opioid use disorder. Clin Toxicol (Phila). 2019 Sep; 57(9):753-759.
Score: 0.551
-
Lai JT, Goldfine CE, Chapman BP, Taylor MM, Rosen RK, Carreiro SP, Babu KM. Nobody Wants to Be Narcan'd: A Pilot Qualitative Analysis of Drug Users' Perspectives on Naloxone. West J Emerg Med. 2021 Feb 08; 22(2):339-345.
Score: 0.157
-
Lai JT, Chapman BP, Carreiro SP, Babu KM, Boyer EW, Chai PR. Understanding Naloxone Uptake from an Emergency Department Distribution Program Using a Low-Energy Bluetooth Real-time Location System. J Med Toxicol. 2020 10; 16(4):405-415.
Score: 0.149
-
Griswold MK, Chai PR, Krotulski AJ, Friscia M, Chapman BP, Varma N, Boyer EW, Logan BK, Babu KM. A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose. J Med Toxicol. 2017 Dec; 13(4):287-292.
Score: 0.125
-
Broach JP, Rettger B, Gigliotti R, Chapman BP, Joseph J, Smiley A, Hunter M, Soucie N, Gross K, Babu KM, Weisberg SN. Creating Opioid Response Specialists: A Harm Reduction Initiative. Prehosp Emerg Care. 2025; 29(4):540-545.
Score: 0.052